Literature DB >> 26796915

Hemostatic alterations during coronary artery bypass grafting.

Chantal L I Gielen1, Anneke Brand2, Waander L van Heerde3, Theo Stijnen4, Robert J M Klautz5, Jeroen Eikenboom6.   

Abstract

INTRODUCTION: The origination of blood loss after cardiac surgery is not fully explained, but is related to operation trauma and use of cardiopulmonary bypass (CPB). However, the extent of their contribution is incompletely known and might differ between distinct operation procedures.
MATERIALS AND METHODS: Three groups of CABG procedures were studied: 1) off-pump coronary artery bypass surgery (OPCAB, n=11) without CPB, 2) CABG with use of CPB (CABG, n=11) and 3) CABG with use of CPB combined with aortic valve replacement (AVR, n=11). Activation of coagulation and fibrinolysis was measured at various time points by flow cytometry, platelet aggregometry, thrombelastography, the Nijmegen Hemostasis Assay, prothrombin fragment 1+2 and tissue plasminogen activator. RESULTS AND
CONCLUSIONS: The use of CPB during cardiac surgery decreased platelet counts, clot strength, fibrinogen, hematocrit and albumin concentrations during the procedure. No perioperative platelet activation was observed and functional (collagen induced) platelet aggregation was transiently impaired, but recovered after surgery in all groups. Patients operated with use of CPB showed increased tissue plasminogen activator concentrations after reperfusion followed by minor and transient fibrinolysis. After all types of surgery coagulation parameters and platelet aggregation showed a rebound above preoperative levels. To conclude, no evident platelet activation, dysfunction or consumption was demonstrated. In patients using tranexamic acid the most prominent factor impairing hemostasis after CABG surgery was hemodilution associated with CPB.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Bleeding, bleeding control; Blood coagulation; Cardiopulmonary bypass; Surgery, complications

Mesh:

Year:  2015        PMID: 26796915     DOI: 10.1016/j.thromres.2015.12.018

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  5 in total

1.  Postoperative thrombotic effects of tranexamic acid in open heart surgery.

Authors:  Ayten Saracoglu; Mehmet Ezelsoy; Kemal Tolga Saracoglu
Journal:  Ir J Med Sci       Date:  2019-02-28       Impact factor: 1.568

2.  Sepsis prediction in critically ill patients by platelet activation markers on ICU admission: a prospective pilot study.

Authors:  Nathalie Layios; Céline Delierneux; Alexandre Hego; Justine Huart; Christian Gosset; Christelle Lecut; Nathalie Maes; Pierre Geurts; Arnaud Joly; Patrizio Lancellotti; Adelin Albert; Pierre Damas; André Gothot; Cécile Oury
Journal:  Intensive Care Med Exp       Date:  2017-07-12

3.  Tranexamic Acid Administered During Off-Pump Coronary Artery Bypass Graft Surgeries Achieves Good Safety Effects and Hemostasis.

Authors:  Enshi Wang; Xin Yuan; Yang Wang; Weinan Chen; Xingtong Zhou; Shengshou Hu; Su Yuan
Journal:  Front Cardiovasc Med       Date:  2022-02-04

Review 4.  Off-Pump Coronary Artery Bypass Grafting: 30 Years of Debate.

Authors:  Mario Gaudino; Gianni D Angelini; Charalambos Antoniades; Faisal Bakaeen; Umberto Benedetto; Antonio M Calafiore; Antonino Di Franco; Michele Di Mauro; Stephen E Fremes; Leonard N Girardi; David Glineur; Juan Grau; Guo-Wei He; Carlo Patrono; John D Puskas; Marc Ruel; Thomas A Schwann; Derrick Y Tam; James Tatoulis; Robert Tranbaugh; Michael Vallely; Marco A Zenati; Michael Mack; David P Taggart
Journal:  J Am Heart Assoc       Date:  2018-08-21       Impact factor: 5.501

5.  Short-term recovery pattern of plasma fibrinogen after cardiac surgery: A prospective observational study.

Authors:  Gabor Erdoes; Wulf Dietrich; Monika Pia Stucki; Tobias Michael Merz; Anne Angelillo-Scherrer; Michael Nagler; Thierry Carrel; Balthasar Eberle
Journal:  PLoS One       Date:  2018-08-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.